Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-23-128246
Filing Date
2023-12-21
Accepted
2023-12-21 16:30:37
Documents
8

Document Format Files

Seq Description Document Type Size
1 424B3 tm2333292d1_424b3.htm 424B3 520836
2 GRAPHIC tm2333292d1_424b3sp2img001.jpg GRAPHIC 5488
3 GRAPHIC tm2333292d1_424b3sp2img002.jpg GRAPHIC 1630
4 GRAPHIC tm2333292d1_424b3sp2img003.jpg GRAPHIC 1891
5 GRAPHIC tm2333292d1_424b3sp2img004.jpg GRAPHIC 1939
6 GRAPHIC tm2333292d1_424b3sp2img005.jpg GRAPHIC 1984
7 GRAPHIC tm2333292d1_424b3sp2img006.jpg GRAPHIC 1738
8 GRAPHIC tm2333292d1_424b3sp2img007.jpg GRAPHIC 2456
  Complete submission text file 0001104659-23-128246.txt   546836
Mailing Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027
Business Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027 (949) 232-1900
Cryoport, Inc. (Filer) CIK: 0001124524 (see all company filings)

EIN.: 880313393 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-251354 | Film No.: 231505719
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)